Information  X 
Enter a valid email address

Petrofac Limited (PFC)

  Print      Mail a friend       Annual reports

Thursday 02 April, 2020

Petrofac Limited

Director/PDMR Shareholding

RNS Number : 6377I
Petrofac Limited
02 April 2020
 

2 April 2020

 

Petrofac Limited (the "Company")

 

Notification of Transaction by

Persons Discharging Managerial Responsibilities (PDMRs)

 

 

Pursuant to the Company's obligations under Market Abuse Regulation 19, the Company hereby c onfirms that today, the following Directors purchased ordinary shares ("Shares") of US$0.02 each in the Company at 199.6 pence per Share on the London Stock Exchange. These purchases are in line with the Company's remuneration arrangements, as published in the 2019 Annual Report and Accounts:

 

Name of Director

Position

Number of Shares purchased on  2 April 2020

Total cumulative disclosable interest held (Shares)

René Médori

Non-executive Chairman

10,020

38,649

Andrea Abt

Non-executive Director

2,505

10,724

Sara Akbar

Non-executive Director

2,505

10,724

Matthias Bichsel

Non-executive Director

2,505

10,724

David Davies

Non-executive Director

2,505

24,956

George Pierson

Non-executive Director

2,505

89,174

Francesca di Carlo

Non-executive Director

2,505

5,786

 

 

The Company's issued share capital consists of 345,912,747 Shares with voting rights. Each Share carries the right to one vote. The Company does not hold any shares in Treasury.

 

 

For further information contact:

 

Alison Flynn, Group Head of Communications

[email protected]  

+44 (0) 207 811 4913

 

Jonathan Yarr, Head of Investor Relations

[email protected]

+44 (0) 207 811 4931

 

Tulchan Communications Group Ltd     

Martin Robinson

Tel: +44 (0) 20 7353 4200

[email protected]

 

LEI 2138004624W8CKCSJ177


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHKKBBQQBKDCQK

a d v e r t i s e m e n t